Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality

The Lancet Respiratory Medicine

Volumn 2, Issue 7, 2014, Pages

  Antes, Gerd ^a   Meerpohl, Joerg J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIDASE INHIBITOR; ANTIVIRUS AGENT; ENZYME INHIBITOR; OSELTAMIVIR; SIALIDASE; ZANAMIVIR;

BIOSTATISTICS; CASE CONTROL STUDY; CASE STUDY; COHORT ANALYSIS; DATA BASE; DRUG EFFECT; EVIDENCE BASED MEDICINE; HUMAN; LETTER; MEDICAL INFORMATION; METHODOLOGY; MORTALITY; OBSERVATIONAL STUDY; PANDEMIC INFLUENZA; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTRATION; ANTAGONISTS AND INHIBITORS; FEMALE; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; MALE; PANDEMIC;

ANTIVIRAL AGENTS; ENZYME INHIBITORS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; NEURAMINIDASE; OSELTAMIVIR; PANDEMICS; ZANAMIVIR;

EID: 84903985356     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(14)70127-4     Document Type: Letter

References (6)

1. Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2014, 2:395-404. for the PRIDE Consortium Investigators.
2. Stewart LA, Tierney JF To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof 2002, 25:76-97.
3. Myles P, Leonardi-Bee J, Van-Tam J, Muthuri S, Venkatesan S A systematic review of the impact of neuraminidase inhibitor antiviral use on outcomes of public health importance during the 2009/10 (swine) influenza A/H1N1v pandemic. PROSPERO International prospective register of systematic reviews (accessed May 8, 2014). http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42011001273#.U3H7aCj4IRk.
4. Muthuri SG, Myles PR, Venkatesan S, et al. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. J Infect Dis 2013, 207:553-563.
5. Roseman M, Milette K, Bero LA, et al. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA 2011, 305:1008-1017.
6. Freemantle N, Shallcross LJ, Kyte D, Rader T, Calvert MJ Oseltamivir: the real world data. BMJ 2014, 348:g2371.